Bone Marrow Adipose Tissue DOI Creative Commons
Elena Marinelli Busilacchi, Erika Morsia, Antonella Poloni

et al.

Cells, Journal Year: 2024, Volume and Issue: 13(9), P. 724 - 724

Published: April 23, 2024

Bone marrow (BM) acts as a dynamic organ within the bone cavity, responsible for hematopoiesis, skeletal remodeling, and immune system control. adipose tissue (BMAT) was long simply considered filler of space, but now it is known that instead constitutes an essential element BM microenvironment participates in homeostasis, influences health alters hematopoietic stem cell functions, contributes to commitment mesenchymal cells, provides effects homeostasis defense against infections, energy metabolism inflammation. BMAT has emerged significant contributor development progression various diseases, shedding light on its complex relationship with health. Notably, been implicated metabolic disorders, hematological malignancies, conditions. shown support proliferation tumor cells acute myeloid leukemia niche adipocytes have found protect cancer chemotherapy, contributing treatment resistance. Moreover, BMAT’s impact density remodeling can lead conditions like osteoporosis, where high levels are inversely correlated mineral density, increasing risk fractures. also associated diabetes, obesity, anorexia nervosa, varying individuals depending their weight status. Understanding interaction between different diseases may new therapeutic strategies.

Language: Английский

Bone Repair Biomaterials: A Perspective from Immunomodulation DOI
Yili Wang, Hao Zhang, Yan Hu

et al.

Advanced Functional Materials, Journal Year: 2022, Volume and Issue: 32(51)

Published: Oct. 9, 2022

Abstract With an increasingly aging society, bone defects and fractures have become significant threats to human health quality of life. Currently, autologous allogeneic grafts remain the “gold standard” for clinical treatment repair. However, transplantation is still clinically insufficient, owing its substantial limitations, such as graft rejection, donor functional defects, risk infection. Therefore, a variety biomaterials been developed facilitate advancement tissue engineering, focus research has transitioned from bioinert bioactive biomaterials. many not achieved satisfactory therapeutic effects. In recent years, advancements in osteoimmunology revealed that immune system, which macrophages are critical components, plays essential regulatory role regeneration. this review, healing explored developments promote regeneration by modulating macrophage polarization improving osteoimmune microenvironment reviewed. This review provides reference development application repair immunomodulation perspective.

Language: Английский

Citations

126

Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases DOI Creative Commons
Jiawei Guo, Fuxiao Wang, Yan Hu

et al.

Cell Reports Medicine, Journal Year: 2023, Volume and Issue: 4(1), P. 100881 - 100881

Published: Jan. 1, 2023

Systematic bone loss is commonly complicated with inflammatory bowel diseases (IBDs) unclear pathogenesis and uncertain treatment. In experimental colitis mouse models established by dextran sulfate sodium IL-10 knockout induced piroxicam, mass quality are significantly decreased. Colitis mice demonstrate a lower formation rate fewer osteoblasts in femur. Bone marrow mesenchymal stem/stromal cells (BMSCs) from tend to differentiate into adipocytes rather than osteoblasts. Serum patients IBD promotes adipogenesis of human BMSCs. RNA sequencing reveals that downregulates Wnt signaling For treatment, exosomes Golgi glycoprotein 1 inserted could carry agonist accumulate via intravenous administration. They alleviate loss, promote formation, accelerate fracture healing mice. Collectively, BMSC commitment microenvironment contributes quantity be rescued redirecting differentiation toward through bone-targeted drug delivery.

Language: Английский

Citations

126

Silk fibroin-based biomaterials for cartilage/osteochondral repair DOI Creative Commons
Ziyang Zhou,

Jin Cui,

Shunli Wu

et al.

Theranostics, Journal Year: 2022, Volume and Issue: 12(11), P. 5103 - 5124

Published: Jan. 1, 2022

Osteoarthritis (OA) is a common joint disease with high disability rate.In addition, OA not only causes great physiological and psychological harm to patients, but also puts pressure on the social healthcare system.Pathologically, disintegration of cartilage lesions subchondral bone are related OA.Currently, tissue engineering, which expected overcome defects existing treatment methods, had lot research in field cartilage/osteochondral repair.Silk fibroin (SF), as natural macromolecular material good biocompatibility, unique mechanical properties, excellent processability degradability, holds potential engineering.Nowadays, SF been prepared into various materials adapt demands repair.SF-based biomaterials can be functionally modified enhance repair performance further.In this review, preparation types, structures, functional modifications SF-based used for summarized discussed.We hope that review will provide reference design development field.

Language: Английский

Citations

121

Osteoporosis pathogenesis and treatment: existing and emerging avenues DOI Creative Commons
Bo Liang, George Burley, Shu Lin

et al.

Cellular & Molecular Biology Letters, Journal Year: 2022, Volume and Issue: 27(1)

Published: Sept. 4, 2022

Abstract Osteoporotic fractures lead to increased disability and mortality in the elderly population. With rapid increase aging population around globe, more effective treatments for osteoporosis osteoporotic are urgently required. The underlying molecular mechanisms of believed be due activity osteoclasts, decreased osteoblasts, or both, which leads an imbalance bone remodeling process with accelerated resorption attenuated formation. Currently, available clinical have mostly focused on factors influencing remodeling; however, they their own limitations side effects. Recently, cytokine immunotherapy, gene therapy, stem cell therapy become new approaches treatment various diseases. This article reviews latest research mechanisms, as well how this underpins current potential novel osteoporosis.

Language: Английский

Citations

117

RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss DOI Open Access
Yan Hu, Xiaoqun Li,

Xin Zhi

et al.

EMBO Reports, Journal Year: 2021, Volume and Issue: 22(7)

Published: June 13, 2021

Language: Английский

Citations

113

Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression DOI Creative Commons
Hao Zhang, Lipeng Wang, Jin Cui

et al.

Science Advances, Journal Year: 2023, Volume and Issue: 9(14)

Published: April 5, 2023

Abnormal subchondral bone remodeling featured by overactivated osteoclastogenesis leads to articular cartilage degeneration and osteoarthritis (OA) progression, but the mechanism is unclear. We used lymphocyte cytosolic protein 1 (Lcp1) knockout mice suppress osteoclasts in a OA model with anterior cruciate ligament transection (ACLT), Lcp1-/- showed decreased retarded degeneration. For mechanisms, activated induced type-H vessels elevated oxygen concentration, which ubiquitylated hypoxia-inducible factor alpha subunit (HIF-1α) chondrocytes led Lcp1 impeded angiogenesis, maintained hypoxia environment joints delayed progression. Stabilization of HIF-1α degeneration, knockdown Hif1a abolished protective effects knockout. Last, we that Oroxylin A, an Lcp1-encoded l-plastin (LPL) inhibitor, could alleviate In conclusion, maintaining hypoxic attractive strategy for treatment.

Language: Английский

Citations

100

Osteoclasts, Master Sculptors of Bone DOI Creative Commons

Deborah J. Veis,

Charles A. O’Brien

Annual Review of Pathology Mechanisms of Disease, Journal Year: 2022, Volume and Issue: 18(1), P. 257 - 281

Published: Oct. 7, 2022

Osteoclasts are multinucleated cells with the unique ability to resorb bone matrix. Excessive production or activation of osteoclasts leads skeletal pathologies that affect a significant portion population. Although therapies effectively target have been developed, they associated sometimes severe side effects, and fuller understanding osteoclast biology may lead more specific treatments. Along those lines, rich body work has defined essential signaling pathways required for formation, function, survival. Nonetheless, recent studies cast new light on long-held views regarding origin these during development homeostasis, their life span, cellular sources factors drive activity homeostasis disease. In this review, we discuss findings in context existing highlight areas ongoing future investigation.

Language: Английский

Citations

99

Bone Marrow Mesenchymal Stromal Cells: Identification, Classification, and Differentiation DOI Creative Commons
Qianmin Gao, Lipeng Wang, Sicheng Wang

et al.

Frontiers in Cell and Developmental Biology, Journal Year: 2022, Volume and Issue: 9

Published: Jan. 3, 2022

Bone marrow mesenchymal stromal cells (BMSCs), identified as pericytes comprising the hematopoietic niche, are a group of heterogeneous composed multipotent stem cells, including osteochondral and adipocyte progenitors. Nevertheless, identification classification still controversial, which limits their application. In recent years, by lineage tracing single-cell sequencing, several new subgroups BMSCs roles in normal physiological pathological conditions have been clarified. Key regulators mechanisms controlling fate being revealed. Cross-talk among bone has demonstrated. this review, we focus on advances BMSCs, provides important implications for clinical applications.

Language: Английский

Citations

98

Diets intervene osteoporosis via gut-bone axis DOI Creative Commons
Yuan‐Wei Zhang,

Peiran Song,

Sicheng Wang

et al.

Gut Microbes, Journal Year: 2024, Volume and Issue: 16(1)

Published: Jan. 4, 2024

Osteoporosis is a systemic skeletal disease that seriously endangers the health of middle-aged and older adults. Recently, with continuous deepening research, an increasing number studies have revealed gut microbiota as potential target for osteoporosis, research concept gut-bone axis has gradually emerged. Additionally, intake dietary nutrients adoption patterns may affect microbiota, alterations in might also influence metabolic status host, thus adjusting bone metabolism. Based on axis, can participate modulation metabolism by altering abundance, diversity, composition microbiota. Herein, combined emerging literatures relevant studies, this review aimed to summarize impacts different components osteoporosis acting well underlying mechanisms proper recommendations.

Language: Английский

Citations

64

Targeting the gut microbiota-related metabolites for osteoporosis: The inextricable connection of gut-bone axis DOI
Yuan‐Wei Zhang, Yan Wu,

Xiang-Fei Liu

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 94, P. 102196 - 102196

Published: Jan. 12, 2024

Language: Английский

Citations

45